These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32741430)

  • 41. Australian Gonococcal Surveillance Programme Annual Report, 2018.
    Lahra MM; Enriquez RP; George CRR
    Commun Dis Intell (2018); 2020 Feb; 44():. PubMed ID: 32114974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effectiveness of patient-delivered partner therapy and chlamydial and gonococcal reinfection in San Francisco.
    Stephens SC; Bernstein KT; Katz MH; Philip SS; Klausner JD
    Sex Transm Dis; 2010 Aug; 37(8):525-9. PubMed ID: 20502392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women.
    Schwebke JR; Desmond RA
    Sex Transm Dis; 2010 Jun; 37(6):392-6. PubMed ID: 20453720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population-level diagnosis and care cascade for chlamydia in Australia.
    Gray RT; Callander D; Hocking JS; McGregor S; McManus H; Dyda A; Moreira C; Braat S; Hengel B; Ward J; Wilson DP; Donovan B; Kaldor JM; Guy RJ
    Sex Transm Infect; 2020 Mar; 96(2):131-136. PubMed ID: 31167824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing Different Partner Notification Methods for Assuring Partner Treatment for Gonorrhea: Looking for the Best Mix of Options.
    Fleming E; Hogben M
    J Public Health Manag Pract; 2017; 23(3):247-254. PubMed ID: 27902560
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Australian Gonococcal Surveillance Programme Annual Report, 2019.
    Lahra MM; Shoushtari M; George CRR; Armstrong BH; Hogan TR;
    Commun Dis Intell (2018); 2020 Jul; 44():. PubMed ID: 32664831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perceived Risk of Intimate Partner Violence Among STI Clinic Patients: Implications for Partner Notification and Patient-Delivered Partner Therapy.
    John SA; Walsh JL; Cho YI; Weinhardt LS
    Arch Sex Behav; 2018 Feb; 47(2):481-492. PubMed ID: 29090392
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Legislate for patient-delivered partner therapy for chlamydia.
    Huffam SE; Brown KM; Chen MY; Fairley CK
    Med J Aust; 2013 Sep; 199(6):387. PubMed ID: 24033199
    [No Abstract]   [Full Text] [Related]  

  • 49. The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment.
    Khan A; Fortenberry JD; Juliar BE; Tu W; Orr DP; Batteiger BE
    Sex Transm Dis; 2005 Apr; 32(4):260-4. PubMed ID: 15788928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient initiated partner treatment for
    Nanhoe AC; Watzeels AJCM; Götz HM
    Int J STD AIDS; 2019 Oct; 30(11):1071-1079. PubMed ID: 31533531
    [No Abstract]   [Full Text] [Related]  

  • 51. Patient-delivered partner therapy for sexually transmitted diseases as practiced by U.S. physicians.
    Hogben M; McCree DH; Golden MR
    Sex Transm Dis; 2005 Feb; 32(2):101-5. PubMed ID: 15668616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Innovative resources could help improve partner notification for chlamydia in primary care.
    Bilardi JE; Hopkins CA; Fairley CK; Hocking JS; Tomnay JE; Pavlin NL; Parker RM; Temple-Smith MJ; Bowden FJ; Russell DB; Pitts M; Chen MY
    Sex Transm Dis; 2009 Dec; 36(12):779-83. PubMed ID: 19704390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Chlamydia Partner Notification Practices and Use of the "Let Them Know" Website by Family Planning Clinicians in Australia: Cross-Sectional Study.
    Guy RJ; Micallef JM; Mooney-Somers J; Jamil MS; Harvey C; Bateson D; van Gemert C; Wand H; Kaldor J
    J Med Internet Res; 2016 Jun; 18(6):e173. PubMed ID: 27342438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Australian Gonococcal Surveillance Programme annual report, 2013.
    Lahra MM;
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E137-45. PubMed ID: 26063087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Partner notification and retesting for Chlamydia trachomatis and Neisseria gonorrhoeae: a case-note review in New Zealand primary care.
    Rose SB; Garrett SM; Kennedy J; Lund K; Hutchings D; Boyle C; Pullon SRH
    J Prim Health Care; 2018 Jun; 10(2):132-139. PubMed ID: 30068468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patient-Delivered Expedited Partner Therapy for Chlamydia trachomatis Infection Among Female Adolescents Using School-Based Health Centers.
    Vacca SH; Salsgiver EL; Gold MA; Neu N
    J Pediatr Health Care; 2019; 33(3):e18-e24. PubMed ID: 30683578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An audit of contact tracing for cases of chlamydia in the Australian Capital Territory.
    England DO; Currie MJ; Bowden FJ
    Sex Health; 2005; 2(4):255-8. PubMed ID: 16402675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of a population-based program of expedited partner therapy for gonorrhea and chlamydial infection.
    Golden MR; Hughes JP; Brewer DD; Holmes KK; Whittington WL; Hogben M; Malinski C; Golding A; Handsfield HH
    Sex Transm Dis; 2007 Aug; 34(8):598-603. PubMed ID: 17413683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Australian Gonococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E. PubMed ID: 28385139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patient-delivered partner therapy for chlamydia: a realistic public health measure in the UK.
    Cameron ST
    BJOG; 2009 Feb; 116(3):345-6. PubMed ID: 19187365
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.